“…4,13,18 Maternal characteristics associated with macrosomic infants born to women without diabetes include obesity, age, excessive weight gain during pregnancy, multiparity, and advanced gestation, as well as genetic predisposition. [19][20][21] In our large cohort of women without diabetes who delivered macrosomic infants, over one-fourth were overweight, and approximately half were either obese, very obese, or extremely obese. Regardless of the mothers' prepregnancy BMI, macrosomia increases the risk of complications during labor and delivery.…”
Section: Discussionmentioning
confidence: 99%
“…Although the incidence of vaginal deliveries decreases, complications such as shoulder dystocia, perinatal asphyxia, and birth injury exist. [19][20][21][22][23] These and other neonatal complications common among macrosomic infants (respiratory distress, hypoglycemia,…”
Section: Discussionmentioning
confidence: 99%
“…The incidence of maternal and neonatal complications among macrosomic infants born to nondiabetic women reported here is similar to that reported in the literature. [19][20][21][22][23] This is relevant to our study because all maternal and neonatal morbidities described above have been known to influence breastfeeding initiation. 8,9,23,24 The influences of obesity on breastfeeding initiation and duration have been well recognized.…”
Intention to breastfeed as well as breastfeeding initiation was significantly lower for extremely obese women. Lack of intention to breastfeed declared during the antepartum period by extremely obese women highlights a need as well as an opportunity for intervention.
“…4,13,18 Maternal characteristics associated with macrosomic infants born to women without diabetes include obesity, age, excessive weight gain during pregnancy, multiparity, and advanced gestation, as well as genetic predisposition. [19][20][21] In our large cohort of women without diabetes who delivered macrosomic infants, over one-fourth were overweight, and approximately half were either obese, very obese, or extremely obese. Regardless of the mothers' prepregnancy BMI, macrosomia increases the risk of complications during labor and delivery.…”
Section: Discussionmentioning
confidence: 99%
“…Although the incidence of vaginal deliveries decreases, complications such as shoulder dystocia, perinatal asphyxia, and birth injury exist. [19][20][21][22][23] These and other neonatal complications common among macrosomic infants (respiratory distress, hypoglycemia,…”
Section: Discussionmentioning
confidence: 99%
“…The incidence of maternal and neonatal complications among macrosomic infants born to nondiabetic women reported here is similar to that reported in the literature. [19][20][21][22][23] This is relevant to our study because all maternal and neonatal morbidities described above have been known to influence breastfeeding initiation. 8,9,23,24 The influences of obesity on breastfeeding initiation and duration have been well recognized.…”
Intention to breastfeed as well as breastfeeding initiation was significantly lower for extremely obese women. Lack of intention to breastfeed declared during the antepartum period by extremely obese women highlights a need as well as an opportunity for intervention.
“…However, it is just this delineation of the normal weight collective from the abnormally under-or overweight fetuses that is of decisive importance for the prenatal and obstetric management. Interuterine growth retardation as well as macrosomia carry significant risks for not only neonatal but also for maternal morbidity and mortality [9][10][11]. A differentiation from the normal collective can only be made when at least the weight estimation can reliably be classified in this range.…”
The estimation of foetal weight is an integral part of prenatal care and obstetric routine. In spite of its known susceptibility to errors in cases of underweight or overweight babies, important obstetric decisions depend on it. In the present contribution we have examined the accuracy and error distribution of 35 weight estimation formulae within the normal weight range of 2500-4000 g. The aim of the study was to identify the weight estimation formulae with the best possible correspondence to the requirements of clinical routine. Materials and Methods: 35 clinically established weight estimation formulae were analysed in 3416 foetuses with weights between 2500 and 4000 g. For this we determined and compared the mean percentage error (MPE), the mean absolute percentage error (MAPE), and the proportions of estimates within the error ranges of 5, 10, 20 and 30%. In addition, separate regression lines were calculated for the relationship between estimated and actual birth weights for the weight range 2500-4000 g. The formulae were thus examined for possible inhomogeneities. Results: The lowest MPE were achieved with the Hadlock III and V formulae (0.8%, STW 9.2 % or, respectively, −0.8 %, STW 10.0 %). The lowest absolute error (6.6 %) as well as the most favourable frequency distribution in cases below 5 % and 10 % error (43.9 and 77.5) were seen for the Halaska formula. In graphic representations of the regression lines, 16 formulae revealed a weight overestimation in the lower weight range and an underestimation in the upper range. 14 formulae gave underestimations and merely 5 gave overestimations over the entire tested weight range. Conclusion: The majority of the tested formulae gave underestimations of the actual birth weight over the entire weight range or at least in the upper weight range. This result supports the cur-
“…По данным литературы [2,3], частота родового травматизма достигает 24%. Уве-личение числа кесаревых сечений способствует уменьше-нию травм плечевого сплетения [2,12,13]. Примечание.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.